Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.

Antiviral therapy - 1 Jan 2010

Schapiro Jonathan M, Scherer Joseph, Boucher Charles A, Baxter John D, Tilke Clemens, Perno Carlo F, Maggiolo Franco, Santoro Maria M, Hall David B

Abstract excerpt

BACKGROUND: The purpose of this study was to develop a tipranavir-weighted mutation score that provides guidance to treating physicians on the relative effect of specific protease mutations on tipranavir activity. METHODS: Weights were developed using data from RESIST tipranavir-treated patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count
Share to Clinical Trials, Phase III as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pyridines

Share to Pyrones

Share to Randomized Controlled Trials as Topic

Share to Ritonavir

Share to Sulfonamides

Source

Identifiers

PMID: 21041916
DOI: 10.3851/IMP1670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21041916-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation score.PMID 21041916Read ↗

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir.Semantic proximity Read ↗

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes.Semantic proximity Read ↗

An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.Semantic proximity Read ↗

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settingsSemantic proximity Read ↗

Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.Semantic proximity Read ↗

Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients.Semantic proximity Read ↗

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.Semantic proximity Read ↗

Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.Semantic proximity Read ↗

Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.Semantic proximity Read ↗

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

Tipranavir/T20-based salvage regimens highly effective and durable against HIV-1 with evidence for genotypic predictability of response in clinical practice.Semantic proximity Read ↗

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.